BSE filing, NSE: WONDERLA. Summary written from the filing by ALFA Finder's alert engine.
Wonderla Holidays Ltd: key numbers
- Share price
- ₹491.35
- Market cap
- ₹3,118 Cr
- Revenue (annual)
- ₹518.8 Cr
- Net profit (annual)
- ₹81.73 Cr
- P/E (TTM)
- 30.6×Sector 33.4×
- Promoter holding
- 62.21%-0.01% QoQ
- FII holding
- 3.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wonderla Holidays Ltd
All →Wonderla Holidays Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Wonderla Holidays Ltd reported revenue from operations of ₹116.6 Cr (+45.4% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Wonderla Holidays Board Meeting Date
Wonderla Holidays convened a board meeting scheduled for 02 Nov 2026 to approve Q1 FY27 unaudited results. No financial figures disclosed in this advance intimation.
Wonderla Holidays Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
Wonderla Holidays Legal & Regulatory
Wonderla Holidays received a GST Show Cause Notice demanding ₹34.28 Crore (inclusive of tax, interest, and penalty). The company is evaluating the notice and will respond.
- Value
- ₹34.28 Cr
Wonderla Holidays Credit Rating
Wonderla Holidays Ltd received a credit rating update from CARE Ratings, reaffirming ratings and revising the outlook for certain long-term facilities.
Wonderla Holidays Annual General Meeting
Wonderla Holidays Limited held its 24th Annual General Meeting on August 19, 2026. Shareholders approved a final dividend of Rs. 2.00 per equity share for FY 2025-26.
Other results update announcements
All →UPL Results Update
UPL's Q2 FY27 revenue was ₹11,860 Cr with EBITDA of ₹2,312 Cr. H1 operational PATMI rose 33% YoY on sustained margin expansion.
Procter & Gamble Health Results Update
P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.
JTL Defence Results Update
JTL Defence reported H1 FY27 revenue of Rs.410 Cr, up 11.4x YoY, with EBITDA of Rs.47 Cr. Adjusted PAT of Rs.3 Cr was impacted by asset revaluation depreciation.
Mold-Tek Packaging Results Update
Mold-Tek reported Q2 FY27 net profit up 36% to Rs 21.06 Cr and H1 profit up 23% to Rs 46.67 Cr. Revenue and sales volumes also rose across both periods.
Epigral Results Update
Epigral reported Q2 FY27 PAT of ₹64 Cr, up 26% YoY, with revenue at ₹752 Cr. EBITDA margin was 18% despite elevated raw material costs.
Eureka Forbes Results Update
Eureka Forbes reported Q2 FY27 revenue of ₹889.6 Cr and PAT of ₹73.3 Cr, both up ~19% YoY. EBITDA margin hit a lifetime high of 13.6%.